Reply to Hartjen et al.
Reply to Hartjen et al.
复制标题
回复 Hartjen 等人。
DOI：
10.1093/infdis/jit142
复制
发表时间：
2013
期刊：
影响因子：
--
通讯作者：
DavidPauza,C
中科院分区：
文献类型：
--
作者：
Boudova,Sarah;Li,Haishan;Sajadi,MohammadM;Redfield,RobertR;Cairo,Cristiana;DavidPauza,C
1. Boudova S、Li H、Sajadi MM、Redfield RR、Pauza CD。HIV持续复制对CD 4阴性V γ 2 V δ 2 T细胞的影响。J Infect Dis 2012; 205：1448-55. 2.李华，彭华，马鹏，等.中国HIV感染密切相关株后Vgamma 2 Vdelta 2 T细胞与疾病进展的关系.中国免疫学杂志，2001，11：117 - 118.临床感染与疾病2008; 46：1466-72.3。Caccamo N，Meraviglia S，Scarpa F，et al. Aminobisphosphonate-activated gammadelta T cells in immunotherapy of cancer：doubts no more.生物治疗专家意见2008; 8：875-83。4. Harris LD，Klatt NR，Vinton C等，SIV感染的亚洲恒河猴中γ δ T细胞亚群扰动的机制。Blood 2010; 116：4148-57. 5. Gioia C，Agrati C，Casetti R等人。免疫功能低下宿主和活动性肺结核期间缺乏CD 27-CD 45 RA-V gamma 9V delta 2+ T细胞效应器。免疫学杂志2002; 168：1484-9. 6. Riedel DJ，Sajadi MM，Armstrong CL，et al. Natural viral suppressors of HIV-1 have a unique capacity to maintain gammadelta T cells.艾滋病2009; 23：1955-64. 7. Urban EM，Li H，Armstrong C，Focaccetti C，Cairo C，Pauza CD.人V γ 2 V δ 2 T细胞中CD 56表达和肿瘤细胞毒性的控制。BMC Immunol 2009; 10：50.
1. Boudova S, Li H, Sajadi MM, Redfield RR, Pauza CD. Impact of persistent HIV replication on CD4 negative Vgamma2Vdelta2 T cells. J Infect Dis 2012; 205: 1448–55. 2. Li H, Peng H, Ma P, et al. Association between Vgamma2Vdelta2 T cells and disease progression after infection with closely related strains of HIV in China. Clin Infect Dis 2008; 46: 1466–72.3. Caccamo N, Meraviglia S, Scarpa F, et al. Aminobisphosphonate-activated gammadelta T cells in immunotherapy of cancer: doubts no more. Expert Opin Biol Ther 2008; 8: 875–83. 4. Harris LD, Klatt NR, Vinton C, et al. Mechanisms underlying gammadelta T-cell subset perturbations in SIV-infected Asian rhesus macaques. Blood 2010; 116: 4148–57. 5. Gioia C, Agrati C, Casetti R, et al. Lack of CD27-CD45RA-V gamma 9V delta 2+ T cell effectors in immunocompromised hosts and during active pulmonary tuberculosis. J Immunol 2002; 168: 1484–9. 6. Riedel DJ, Sajadi MM, Armstrong CL, et al. Natural viral suppressors of HIV-1 have a unique capacity to maintain gammadelta T cells. Aids 2009; 23: 1955–64. 7. Urban EM, Li H, Armstrong C, Focaccetti C, Cairo C, Pauza CD. Control of CD56 expression and tumor cell cytotoxicity in human Vgamma2Vdelta2 T cells. BMC Immunol 2009; 10: 50.